Logo image of OBEL.BR

ORANGE BELGIUM (OBEL.BR) Stock Fundamental Analysis

EBR:OBEL - BE0003735496 - Common Stock

18.45 EUR
0 (0%)
Last: 8/25/2025, 5:21:04 PM
Fundamental Rating

3

Taking everything into account, OBEL scores 3 out of 10 in our fundamental rating. OBEL was compared to 6 industry peers in the Wireless Telecommunication Services industry. There are concerns on the financial health of OBEL while its profitability can be described as average. OBEL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

OBEL had positive earnings in the past year.
OBEL had a positive operating cash flow in the past year.
Each year in the past 5 years OBEL has been profitable.
Each year in the past 5 years OBEL had a positive operating cash flow.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of OBEL (0.93%) is comparable to the rest of the industry.
The Return On Equity of OBEL (3.88%) is better than 66.67% of its industry peers.
The Return On Invested Capital of OBEL (3.63%) is better than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for OBEL is below the industry average of 6.64%.
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROIC 3.64%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.89%, OBEL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
OBEL's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 7.62%, OBEL perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
OBEL's Operating Margin has improved in the last couple of years.
The Gross Margin of OBEL (68.11%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of OBEL has grown nicely.
Industry RankSector Rank
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

0

2. Health

2.1 Basic Checks

OBEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
OBEL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OBEL has been increased compared to 5 years ago.
Compared to 1 year ago, OBEL has an improved debt to assets ratio.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.95, we must say that OBEL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OBEL (0.95) is worse than 66.67% of its industry peers.
The Debt to FCF ratio of OBEL is 23.91, which is on the high side as it means it would take OBEL, 23.91 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 23.91, OBEL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
OBEL has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of OBEL (1.92) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Altman-Z 0.95
ROIC/WACC0.69
WACC5.24%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

OBEL has a Current Ratio of 0.49. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
OBEL has a Current ratio of 0.49. This is amonst the worse of the industry: OBEL underperforms 83.33% of its industry peers.
A Quick Ratio of 0.46 indicates that OBEL may have some problems paying its short term obligations.
With a Quick ratio value of 0.46, OBEL is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.46
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

OBEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 780.62%, which is quite impressive.
OBEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.64% yearly.
OBEL shows a decrease in Revenue. In the last year, the revenue decreased by -0.39%.
OBEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.26% yearly.
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%

3.2 Future

OBEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.42% yearly.
Based on estimates for the next years, OBEL will show a very negative growth in Revenue. The Revenue will decrease by -10.97% on average per year.
EPS Next Y-67.31%
EPS Next 2Y-52.22%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue Next Year3.5%
Revenue Next 2Y2.16%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.75, which means the current valuation is very expensive for OBEL.
Compared to the rest of the industry, the Price/Earnings ratio of OBEL indicates a slightly more expensive valuation: OBEL is more expensive than 66.67% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.24. OBEL is around the same levels.
The Forward Price/Earnings Ratio is negative for OBEL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 30.75
Fwd PE N/A
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

OBEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OBEL is cheaper than 83.33% of the companies in the same industry.
OBEL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. OBEL is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.14
EV/EBITDA 5.3
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The decent profitability rating of OBEL may justify a higher PE ratio.
OBEL's earnings are expected to grow with 33.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.22%
EPS Next 3Y33.42%

0

5. Dividend

5.1 Amount

No dividends for OBEL!.
Industry RankSector Rank
Dividend Yield N/A

ORANGE BELGIUM

EBR:OBEL (8/25/2025, 5:21:04 PM)

18.45

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)07-24 2025-07-24
Earnings (Next)02-05 2026-02-05/amc
Inst Owners5.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.24B
Analysts77.78
Price Target20.57 (11.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-57.8%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)14.15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.97%
EPS NY rev (3m)-78.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.31%
Revenue NY rev (3m)2.31%
Valuation
Industry RankSector Rank
PE 30.75
Fwd PE N/A
P/S 0.63
P/FCF 14.14
P/OCF 2.63
P/B 1.29
P/tB N/A
EV/EBITDA 5.3
EPS(TTM)0.6
EY3.25%
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)1.3
FCFY7.07%
OCF(TTM)7.01
OCFY38.01%
SpS29.36
BVpS14.28
TBVpS-9.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROCE 4.85%
ROIC 3.64%
ROICexc 3.7%
ROICexgc 7.68%
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
FCFM 4.44%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
ROICexc(3y)4.56%
ROICexc(5y)5.09%
ROICexgc(3y)11.41%
ROICexgc(5y)10.53%
ROCE(3y)6.22%
ROCE(5y)6.69%
ROICexcg growth 3Y-7.87%
ROICexcg growth 5Y2.19%
ROICexc growth 3Y-16.49%
ROICexc growth 5Y-3.51%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Debt/EBITDA 2.97
Cap/Depr 81.82%
Cap/Sales 19.45%
Interest Coverage 1.49
Cash Conversion 76.13%
Profit Quality 235.44%
Current Ratio 0.49
Quick Ratio 0.46
Altman-Z 0.95
F-Score7
WACC5.24%
ROIC/WACC0.69
Cap/Depr(3y)156.85%
Cap/Depr(5y)119.41%
Cap/Sales(3y)34.82%
Cap/Sales(5y)26.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
EPS Next Y-67.31%
EPS Next 2Y-52.22%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%
Revenue Next Year3.5%
Revenue Next 2Y2.16%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%
EBIT growth 1Y12.37%
EBIT growth 3Y22.15%
EBIT growth 5Y18.64%
EBIT Next Year291.94%
EBIT Next 3Y57.64%
EBIT Next 5Y21.59%
FCF growth 1Y116.96%
FCF growth 3Y-9.07%
FCF growth 5Y-7.65%
OCF growth 1Y24.22%
OCF growth 3Y10.98%
OCF growth 5Y8.17%